Evidence
Reading a psilocybin trial without the press release
Effect sizes, blinding problems, and why a study everyone shared last month says less than it appeared to.
The exact phrase for a field about to stop being fringe.
Below is a concept, not a real business. One version of what you could build on psychedelicsmentalhealth.com.
Psychedelics & Mental Health
Evidence
Independent coverage of psychedelic medicine: trial results read properly, state and federal legality tracked, and how to find a provider who is actually licensed.
SubscribeEvidence
Effect sizes, blinding problems, and why a study everyone shared last month says less than it appeared to.
Regulation
What has been submitted, what was asked for in response, and what that means for a timeline.
Legality
Decriminalization, supervised-use programs, and federal scheduling are three different things people routinely conflate.
Providers
Licensure, supervision, and screening. The gap between the two is where the harm happens.
One issue a week, evidence first.
Psilocybin and MDMA therapies are moving through approval processes that will end with regulated products and a great deal of public confusion. The people who will need trustworthy information are patients, clinicians, and regulators, and almost nobody is serving all three.
The name is also usefully clinical. It says mental health rather than psychedelia, which is the difference between a publication a doctor will cite and one they will not.
Some ideas
None of these are the "right" answer. They're just starting points, and if you have a better one, we'd genuinely like to hear it.
A field with fast-moving evidence and no established outlet is exactly where a title can be built quickly and then defended for a long time.
Once supervised use is legal in more states, patients will need a way to find real clinics. That directory is worth building before the demand arrives.
Therapists will need credentials in this, and the bodies issuing them are still forming.
If you are opening clinics, owning the category phrase is worth more than any amount of paid search.
If you want it
Most domains are sold by people who only sell domains. Savo Group is a design, software, and marketing company, so if you want psychedelicsmentalhealth.com live and working rather than parked, that is a conversation we can actually have. Entirely optional, quoted separately from the name, and no hard feelings if you already have a team.
Identity, site design, and the whole visual system. If you have a name and nothing else, this is where it starts.
Web apps, platforms, integrations. The thing itself, not just the site that describes it.
SEO, content, and paid acquisition. Getting the domain found once it has something worth finding.
Tick the box on the offer form and we will include some thoughts on what psychedelicsmentalhealth.com could become when we reply. Or say nothing, and we will just talk about the domain.
Terms
Not every buyer is in the same position, so the domain is available on any of the following. Tell us which suits you and we will put figures against it.
$14,888
Pay in full and own it outright.
$1,240.67/mo
Spread the cost over agreed installments.
Agreed with you
Use the domain without buying it.
Whichever route you take, there is no broker in the middle and no commission added to the price. Offers receive a reply within one business day.
Names like this tend to sit until someone decides they want it, and then move quickly. If you're weighing it up, send a number and start the conversation. There's no obligation on either side.